...
首页> 外文期刊>Biological & pharmaceutical bulletin >Metabolites of Hirsuteine and Hirsutine,the Major Indole Alkaloids of Uncaria rhynchophylla,in Rats
【24h】

Metabolites of Hirsuteine and Hirsutine,the Major Indole Alkaloids of Uncaria rhynchophylla,in Rats

机译:大鼠钩藤中主要的吲哚生物碱-水ute碱和水rs碱的代谢产物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The metabolic fate of hirsuteine (HT) and hirsutine (HS),the major indole alkaloids of Uncaria rhyn-chophylla,was investigated using rats.On HPLC analysis,urine from rats orally administered HT were found to contain two metabolites (HT1 and HT2) together with unchanged HT.Similarly HS also was metabolized to two compounds (HS1 and HS2).Metabolite structures were determined to be ll-hydroxyhirsuteine-ll-O-beta-D-glu-curonide (HT1),11-hydroxyhirsuteine (HT2),ll-hydroxyhirsutine-ll-O-beta-D-glucuronide (HS1) and 11-hydroxy-hirsutine (HS2),based on spectroscopic and chemical data.HT1 and HS1 were also detected in bile from rats ad-ministered HT and HS,respectively.Total cumulative urinary excretion within 72 h of oral administration was approximately 14% and 26% of the HT and HS doses,respectively,while total cumulative biliary excretion was 35% and 46%,respectively.HT and HS 11-hydroxylation were catalyzed by rat liver microsomes.This 11-hy-droxylation activity was inhibited by addition of SKF-525A (a nonselective CYP inhibitor) or cimetidine (a CYP2C inhibitor).These results indicate that orally administered HT and HS are converted to 11-hydroxy metabolites in rats,and that the metabolites are predominantly excreted in bile rather than urine following glu-curonidation.Furthermore,the results suggest that CYP2C enzymes are involved,at least in part,in the specific 11-hydroxylation of HT and HS.
机译:用大鼠研究了钩藤钩虫的主要吲哚生物碱水飞碱(HT)和水苏素(HS)的代谢命运。通过HPLC分析,发现口服HT的大鼠尿中含有两种代谢物(HT1和HT2)。类似地,HS也被代谢为两种化合物(HS1和HS2),代谢物结构被确定为ll-羟基水ute素-ll-O-β-D-glu-curonide(HT1),11-羟基水s素(HT2) ,根据光谱和化学数据,分别测定11,2-羟基-水苏糖醇-II-O-β-D-葡萄糖醛酸(HS1)和11-羟基-水苏糖苷(HS2)。口服72小时内的总累积尿排泄分别约为HT和HS剂量的14%和26%,而总累积胆汁排泄分别分别为HT和HS剂量的35%和46%。鼠肝微粒体催化这种11-羟基氧化反应活性f SKF-525A(一种非选择性CYP抑制剂)或西咪替丁(一种CYP2C抑制剂)。这些结果表明,口服给予的HT和HS在大鼠中转化为11-羟基代谢物,代谢物主要在胆汁而非尿液中排泄。此外,该结果表明CYP2C酶至少部分参与HT和HS的特异性11-羟基化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号